MedTrace Logo

The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

NCT04129125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2025-08-08

Study results available
· View outcomes & findings →

Summary

The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System in subjects diagnosed with acute ischemic stroke and undergoing a thrombectomy procedure within 8 hours of last known well.

Conditions

Interventions

DEVICE

Zoom Reperfusion System

Thrombectomy

Sponsors & Collaborators

  • Imperative Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Raul G Nogueira, MD · University of Pittsburgh

  • Reade A De Leacy, MD · Icahn School of Medicine at Mount Sinai

  • William J Mack, MD · University of Southern California

  • Emir Deljkich · Imperative Care, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2024-05-28
Completion
2024-05-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04129125 on ClinicalTrials.gov